Table 1.
The clinicopathological features of MTHFD1L in TSCC.
| Variable | MTHFD1L | P | ||
|---|---|---|---|---|
| Low | Medium | High | ||
| AGE | ||||
| <60 | 18 | 53 | 3 | 0.024 |
| ≥60 | 12 | 15 | 5 | |
| GENDER | ||||
| Male | 14 | 42 | 6 | 0.232 |
| Female | 16 | 26 | 2 | |
| T CLASSIFICATION | ||||
| I | 26 | 44 | 1 | |
| II | 3 | 19 | 1 | <0.001 |
| III | 0 | 2 | 2 | |
| IV | 1 | 3 | 4 | |
| N CLASSIFICATION | ||||
| N0 | 28 | 50 | 3 | 0.003 |
| Nx | 2 | 18 | 5 | |
| M classification | ||||
| M0 | 30 | 67 | 8 | 0.754 |
| M1 | 0 | 1 | 0 | |
| TNM STAGING | ||||
| I | 25 | 39 | 1 | |
| II | 3 | 11 | 1 | 0.001 |
| III | 0 | 8 | 1 | |
| IV | 2 | 10 | 5 | |
| DIFFERENTIATION STAGE | ||||
| I | 24 | 45 | 4 | |
| II | 5 | 19 | 3 | 0.476 |
| III | 1 | 4 | 1 | |
| RECURRENCE | ||||
| Yes | 23 | 53 | 5 | 0.622 |
| No | 7 | 15 | 3 | |
The relation between the MTHFD1L expression and the clinicopathologic characteristics of TSCC.
Bold means the p value is less than 0.05, which is statistically significant.